Volume 12, Number 6, June 2006

Acanthamoeba Encephalitis in Patient with Systemic Lupus, India

Charudatt G. Shirwadkar,* Rohini Samant,* Milind Sankhe,* Ramesh Deshpande,* Shigeo Yagi,† Frederick L. Schuster,† Rama Sriram,‡ and Govinda S. Visvesvara‡
*P.D. Hinduja National Hospital and Research Centre, Mumbai, India; †California Department of Health Services, Richmond, California, USA; and ‡Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Figure 2. Results of polymerase chain reaction showing 230-bp and 161-bp bands for Balamuthia (lanes 1–6) and Acanthamoeba (lanes 7–12) mitochondrial 16S rRNA gene DNA. Lane 1, molecular mass marker; lane 2, absence of Balamuthia DNA in patient brain tissue (5-μL sample); lane 3, positive control (Balamuthia DNA); lane 4, negative control (Acanthamoeba DNA); lane 5, negative control (water); lane 6, absence of Balamuthia DNA in patient brain tissue (1-μL sample); lane 7, molecular mass marker; lane 8, Acanthamoeba DNA isolated from patient brain tissue (5-μL sample); lane 9, absence of Balamuthia DNA isolated from amebae in patient sample; lane 10, positive control (Acanthamoeba DNA); lane 11, negative control (water); lane 12, Acanthamoeba DNA isolated from patient brain tissue (1-μL sample).

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed May 18, 2006

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention